Report urges companies to hunt for more value from their patents
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
Brian Tenner sits down with IAM to discuss the company’s win and future strategy
GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation
Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible
13 April 2021
Paris Court of Appeal turns down three appeals over supplementary protection certificate rejections
12 April 2021
As political wrangling and potential for commercial fallout mounted, the two Korean battery suppliers reached an eleventh-hour settlement deal yesterday
12 April 2021
Hub-and-spokes life sciences companies are providing new opportunities for IP monetisation
08 April 2021
SCOTUS petition denial in Argentum v Novartis highlights the difficult choices facing those who wish to challenge patents at the PTAB
06 April 2021
A new starting point for calculating cost awards in complex disputes could help to deter lengthy or unnecessary patent proceedings
05 April 2021
Financial figures disclosed as supplement to IPO prospectus, in latest sign regulators are wary of waving through companies facing major overseas IP litigation
26 March 2021
A surge in life sciences applications offset a disappointing performance in other areas, the latest EPO statistics suggest
25 March 2021
25 March 2021
Unlock unlimited access to all IAM content